Stage I Invasive Ductal Carcinoma: Julie's Patient Story

Patient Info: Julie Martin, Female | Stage I

Julie completed surgery and a five-day proton-radiation course for stage I breast cancer and continued annual mammographic surveillance.

The Patient StoryRead more →

Stage IV Colorectal Adenocarcinoma: Darrell's Survivor Story

Patient Info: Darrell Sawyer, Male | Stage IV

Metastatic Site: Liver

As of February 2017, Darrell had completed surgery, portal vein embolization, liver resection and chemotherapy for Stage IV sigmoid adenocarcinoma and was living with treatment effects including neuropathy, vision changes, weight loss and chemobrain.

MD AndersonRead more →

Stage II Breast Cancer: Natalia's Survivor Story

Patient Info: Natalia | Stage II

Natalia was declared cancer-free on February 21, 2024, and continued regular follow-up while taking letrozole.

Our Cancer StoriesRead more →

BRCA1 Non-Small Cell Lung Cancer: Nadine's Survivor Story

Patient Info: Nadine Beech, Female, Under 40

Biomarkers: Germline BRCA1 mutation for hereditary breast/ovarian cancer risk; lung cancer biomarker not reported

As of November 2016, Nadine was cancer-free after right bilobectomy for recurrent non-small cell lung cancer, following 19 years of lung cancer management that included left lower lobectomy, surveillance, Tarceva, and risk-reducing surgery for germline BRCA1.

MD AndersonRead more →

Lung cancer follow-up: returning to golf while living with an ongoing tumor

Patient Info: Anonymized, Male

As of September 2015, he was more than 1.5 years from diagnosis, the tumor was still present, treatment side effects varied by day, and he was waiting for the next control CT while trying to return to normal activities such as golf.

Lung cancer on Tarceva with stable symptoms during summer follow-up

Patient Info: Anonymized, Male

As of July 2015, he was continuing Tarceva, felt strong overall, had no major cancer symptoms, and was waiting until October for the next CT while assuming the tumor remained stable.

Lung cancer follow-up with hopeful CT results and a treatment respite

Patient Info: Anonymized, Male

As of March 2015, the latest CT was described as encouraging and gave him a period of respite from tests and hospital stress, although ongoing follow-up remained necessary.

Lung cancer first-anniversary survival milestone with slower-than-expected tumor growth

Patient Info: Anonymized, Male

As of January 2015, he had reached 1 year since lung cancer detection, with slower-than-expected tumor growth and treatment that had given him an uncertain but meaningful extension of time.

EGFR-mutated lung cancer diary: PET-scan anxiety during treatment break

Patient Info: Anonymized, Male

Biomarkers: EGFR mutation

As of December 2014, the patient had been off treatment for 6 months with limited symptoms and was awaiting a PET scan to determine whether treatment should restart.

Lung cancer diary: treatment-free interval while waiting for PET

Patient Info: Anonymized, Male

As of November 2014, the patient was in a treatment-free interval with no appreciable symptoms and was waiting for a PET scan on 9 December to reassess tumor behavior.

Lung cancer diary: chemotherapy completed and supportive symptom strategies

Patient Info: Anonymized, Male

As of October 2014, the patient had completed chemotherapy, was not reporting major symptoms, and had a PET scan scheduled for 9 December to reassess the disease.

Precancerous polyps / familial colorectal cancer risk prevention; no confirmed colorectal cancer diagnosis: Terri's Patient Story

Patient Info: Terri Hofmeister, Female, Under 40

Biomarkers: Familial cancer disorder suspected/indicated; specific genetic alteration not reported

As of November 2011, Terri had no confirmed colorectal cancer diagnosis; colonoscopy found many polyps and a precancerous polyp, and preventive total proctocolectomy with J-pouch helped reduce future colorectal cancer risk.

Cleveland ClinicRead more →